P

Patient Square Capital

48 employees

Patient Square Capital is a health care investment firm that will make investments by partnering with management teams whose products.

Investor insights

Sectors invested in

Biotechnology6
Health Care5
Life Science4
Gene Therapy3
Single Cell1
Pharmaceutical1
Product Research1
Biopharma1
Medical1
Genetics1
Cell Atlasing1
Transcriptomics1
Oncology1
Infectious Diseases1
Genomics1
Imaging1
Spatial Biology1
Neuroscience1
Agrigenomics1
Single-cell1

Funding rounds participated in

$150M sweet spot round size

Most of their 9 investments are in rounds between $100M and $226M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Sectors

Financial Services
Health Care
Finance

Date founded

2020

Investments made

U

Undisclosed raised $226M on September 6, 2023

Investors: M&G plc and Patient Square Capital

K

Kriya Therapeutics raised $150M on July 26, 2023

Investors: Patient Square Capital

U

Undisclosed raised $300M on May 1, 2023

Investors: Patient Square Capital

R

Resolve Biosciences raised $71M on October 24, 2022

Investors: PS Capital Management, Alafi Capital Corp, EDBI Pte Ltd, High-Tech Gründerfonds, NRW.BANK and Patient Square Capital

A

Alladapt Immunotherapeutics, Inc. raised $119M on June 22, 2022

Investors: Red Tree Venture Capital, Gurnet Point Capital, WestRiver Group and Patient Square Capital

K

Kriya Therapeutics raised $270M on May 16, 2022

Investors: Narya, Transhuman Capital, Dexcel Pharma, QVT Financial LLP, Foresite Capital, JDRF T1D Fund and Patient Square Capital

R

Roivant Sciences raised $200M on October 1, 2021

Investors: Suvretta Capital Management LLC, Dainippon Sumitomo Pharma, Palantir Technologies, Viking Global Investors, Eventide Asset Management, RTW Investments, LP and Patient Square Capital

K

Kriya Therapeutics raised $100M on July 14, 2021

Investors: Narya, Transhuman Capital, QVT Financial LLP, Dexcel Pharma, Foresite Capital, Woodline Partners LP, JDRF T1D Fund and Patient Square Capital

U

Undisclosed raised $140M on June 17, 2021

Investors: UCL Technology Fund, Reimagined Ventures and Patient Square Capital

FAQ